(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037008-100mg
|
≥98%,99%e.e. |
1297613-76-3 |
100mg
|
¥ 5197.0
|
5-7天 |
科威 |
(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037007-100mg
|
≥98%,99%e.e. |
1297613-75-2 |
100mg
|
¥ 5200.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037006-100mg
|
≥98%,99%e.e. |
1297613-74-1 |
100mg
|
¥ 5397.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037005-100mg
|
≥98%,99%e.e. |
1297613-73-0 |
100mg
|
¥ 5403.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037004-100mg
|
≥98%,99%e.e. |
1297613-72-9 |
100mg
|
¥ 4899.0
|
5-7天 |
科威 |
(R)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
K037003-100mg
|
≥95%,99%e.e. |
1297613-71-8 |
100mg
|
¥ 5571.0
|
5-7天 |
科威 |
(R)-2,2',3,3'-Tetrahydro-6,6'-di(2-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol
|
K037002-100mg
|
≥98%,99%e.e. |
1297613-70-7 |
100mg
|
¥ 4099.0
|
5-7天 |
科威 |
5-羟基甲基烟酸甲酯
|
K037001-250mg
|
97% |
129747-52-0 |
250mg
|
¥ 660.0
|
5-7天 |
科威 |
5-羟基甲基烟酸甲酯
|
K037001-50mg
|
97% |
129747-52-0 |
50mg
|
¥ 220.0
|
5-7天 |
科威 |
3-噻吩苯甲醛
|
K037000-100mg
|
95% |
129746-42-5 |
100mg
|
¥ 816.0
|
5-7天 |
科威 |
3-噻吩苯甲醛
|
K037000-25mg
|
95% |
129746-42-5 |
25mg
|
¥ 340.0
|
5-7天 |
科威 |
2-(3-氨基苯)乙酰胺
|
K036999-250mg
|
96% |
129743-47-1 |
250mg
|
¥ 949.0
|
5-7天 |
科威 |
2-(3-氨基苯)乙酰胺
|
K036999-50mg
|
96% |
129743-47-1 |
50mg
|
¥ 316.0
|
5-7天 |
科威 |
7-[4-[4-(2,3-二氯苯基)-1-哌嗪基]丁氧基]-2(1H)-喹啉酮
|
K036998-100mg
|
97% |
129722-25-4 |
100mg
|
¥ 1371.0
|
5-7天 |
科威 |
7-[4-[4-(2,3-二氯苯基)-1-哌嗪基]丁氧基]-2(1H)-喹啉酮
|
K036998-25mg
|
97% |
129722-25-4 |
25mg
|
¥ 571.0
|
5-7天 |
科威 |
6-溴喹啉-3-甲酰胺
|
K036997-50mg
|
97% |
1296950-96-3 |
50mg
|
¥ 970.0
|
5-7天 |
科威 |
6-溴-3,4-二氢-1H-[1,8]萘啶-2-酮
|
K036996-1g
|
95% |
129686-16-4 |
1g
|
¥ 1035.0
|
5-7天 |
科威 |
6-溴-3,4-二氢-1H-[1,8]萘啶-2-酮
|
K036996-250mg
|
95% |
129686-16-4 |
250mg
|
¥ 431.0
|
5-7天 |
科威 |
7-氯咪唑并[1,2-a]吡啶-3-甲酸乙酯
|
K036995-1g
|
95% |
1296201-68-7 |
1g
|
¥ 2497.0
|
5-7天 |
科威 |
4,7-二溴-5,6-二氟-2,1,3-苯并噻二唑
|
K036994-100mg
|
>98.0%(GC) |
1295502-53-2 |
100mg
|
¥ 1649.0
|
5-7天 |
科威 |
N-甲基-3-苯氧基苄胺
|
K036993-5g
|
≥97% |
129535-78-0 |
5g
|
¥ 2319.0
|
5-7天 |
科威 |
N-甲基-3-苯氧基苄胺
|
K036993-1g
|
≥97% |
129535-78-0 |
1g
|
¥ 1249.0
|
5-7天 |
科威 |
2-氯甲基-4-苄基高吗啉
|
K036992-1g
|
≥95% |
129482-45-7 |
1g
|
¥ 1403.0
|
5-7天 |
科威 |
2-氯甲基-4-苄基高吗啉
|
K036992-250mg
|
≥95% |
129482-45-7 |
250mg
|
¥ 713.0
|
5-7天 |
科威 |